MedPath

Evaluation of Mechanisms Responsible for Coma in Patients Affected by Fulminant, Acute and Chronic Hepatic Failure

Terminated
Conditions
Acute and Chronic Hepatic Failure With Developing Coma
Registration Number
NCT01582087
Lead Sponsor
The University of Texas Medical Branch, Galveston
Brief Summary

The purpose of this study is to understand mechanisms associated with the development of coma during hepatic failure. As of today, those mechanisms are not understood and it is difficult to intervene and prevent coma development which is often associated with mortality. Understanding the mechanism involved, may allow us to prevent coma and develop new therapies to treat this disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • Patients (male or female), 18 years or older hospitalized or seen at UTMB clinics for chronic or acute hepatic failure will be included in the study.
Exclusion Criteria
  • Patients (male or female), 18 years or older hospitalized or seen at UTMB clinics that do not have a diagnosis of chronic or acute hepatic failure

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The relationship that exist between a liver undergoing chronic or acute degeneration and hepatic coma.8 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The University of Texas Medical Branch

🇺🇸

Galveston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath